
Rainbow Childrens Medicare Ltd is Rated Sell
2026-05-11 10:10:02Rainbow Childrens Medicare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 22 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Rainbow Childrens Medicare Ltd Valuation Shifts Signal Elevated Price Risk
2026-05-07 08:02:16Rainbow Childrens Medicare Ltd, a small-cap player in the hospital sector, has seen its valuation parameters shift markedly towards the expensive end of the spectrum, raising questions about its price attractiveness amid sector peers and historical benchmarks. Despite a recent upgrade in market sentiment reflected in a 2.18% day gain, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now position it as very expensive, prompting a reassessment of its investment appeal.
Read More
Rainbow Childrens Medicare Ltd is Rated Sell
2026-04-30 10:10:20Rainbow Childrens Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Rainbow Childrens Medicare Ltd is Rated Sell
2026-04-19 10:10:14Rainbow Childrens Medicare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 22 September 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read More
Rainbow Childrens Medicare Ltd Valuation Shifts Signal Heightened Price Risk
2026-04-15 08:03:08Rainbow Childrens Medicare Ltd has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating, raising concerns about price attractiveness amid a challenging market backdrop. Despite recent gains, the stock’s elevated price-to-earnings and price-to-book ratios suggest investors should carefully weigh the risks against potential rewards.
Read More
Rainbow Childrens Medicare Ltd is Rated Sell
2026-04-08 10:10:19Rainbow Childrens Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read More
Rainbow Childrens Medicare Ltd Surges 9.2% to Day's High of Rs 1255.5 — Outperforms Sector by 6.7 Percentage Points
2026-04-07 14:01:02The Sensex edged down by 0.02% on 7 Apr 2026, while Rainbow Childrens Medicare Ltd surged 9.19%, outperforming its hospital sector peers by 6.7 percentage points. This sharp single-session gain rewrites the short-term narrative for the small-cap stock, which has been on a modest recovery path after recent weakness.
Read More
Rainbow Childrens Medicare Ltd is Rated Sell
2026-03-28 10:10:03Rainbow Childrens Medicare Ltd is rated Sell by MarketsMOJO. This rating was last updated on 22 September 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 28 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
01-Jun-2026 | Source : BSEEarnings call transcript for the financial results Q4 FY26
March 31 2026
27-May-2026 | Source : BSEFinancial Results approved in the Board Meeting dated March 23 2026.
March 31 2026
27-May-2026 | Source : BSEFinancial Results approved in the Board Meeting held on May 23 2026.
Corporate Actions
No Upcoming Board Meetings
Rainbow Childrens Medicare Ltd has declared 35% dividend, ex-date: 21 Jul 26
No Splits history available
No Bonus history available
No Rights history available